HER-2/neu expression as a predictor of response to neoadjuvant docetaxel in patients with operable breast carcinoma

Peter A. Learn, I. Tien Yeh, Michelle McNutt, Gary B. Chisholm, Brad H. Pollock, Dennis L. Rousseau, Frances E. Sharkey, Anatolio B. Cruz, Morton S. Kahlenberg*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

46 Scopus citations

Fingerprint

Dive into the research topics of 'HER-2/neu expression as a predictor of response to neoadjuvant docetaxel in patients with operable breast carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences